News

citefactor-journal-indexing

Investigation of Interferon beta-1a as Multiple Sclerosis (MS) Medication in Human Serum Albumin in Biopharmaceutical Formulation

Multiple sclerosis, or MS, is a long-lasting disease that can affect your brain, spinal cord, and the optic nerves in your eyes. It can cause problems with vision, balance, muscle control, and other basic body functions. IFN-beta treatment reduces the relapse rate in multiple sclerosis (MS), but the exact mechanism of action of the drug has remained elusive. CD73 (ecto-5'-nucleotidase) is an ectoenzyme, which produces adenosine from adenosine monophosphate (AMP) precursor by enzymatic dephosphorylation. In this study, a validated and rapid HPLC method for quantification of human serum albumin in interferon beta-1a biopharmaceutical formulation was developed and linearity, robustness, specificity, accuracy and precision of samples were determined.



Real Time Impact Factor: Pending

Author Name:

URL: View PDF

Keywords: Multiple Sclerosis (MS); Human Serum Albumin; Interferon beta-1a; robustness; Specificity

ISSN: 2209-2528

EISSN: 2209-2536


EOI/DOI: 10.22034/MBT.2017.60336


Add Citation Views: 1














Search


Advance Search

Get Eoi for your journal/conference/thesis paper.

Note: Get EOI for Journal/Conference/ Thesis paper.
(contact: eoi@citefactor.org).

citefactor-paper-indexing

Share With Us












Directory Indexing of International Research Journals